uniQure (NASDAQ:QURE – Get Free Report) had its price objective reduced by analysts at Stifel Nicolaus from $50.00 to $40.00 in a report issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Stifel Nicolaus’ price target indicates a potential upside of 100.35% from the company’s current price. Several [...]
Stifel Nicolaus Lowers uniQure (NASDAQ:QURE) Price Target to $40.00
